Health Canada Warns Against Xiadafil VIP Tabs
Health Canada is advising consumers not to use Xiadafil VIP Tabs due to concerns about possible side-effects.
Xiadafil VIP Tabs is promoted as an "all natural" dietary supplement used for sexual enhancement and the treatment of erectile dysfunction. The product is packaged in bottles of 8 tablets (Lot # 6K029) and in blister cards of 2 tablets (Lot #6K029-SEI).
Reason for Warning
At the request of the U.S. Food and Drug Administration, U.S. federal authorities seized all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot #6K029) and blister cards of 2 tablets (Lot #6K029-SEI) because they were found to contain undeclared hydroxyhomosildenafil, a compound similar in structure to sildenafil. These lots of Xiadafil VIP Tabs have an expiration date of September 2009 (09/09).
Sildenafil is a prescription drug used for the treatment of erectile dysfunction, and should only be taken under the supervision of a health care professional.
Unsupervised use of sildenafil by patients with heart disease can result in serious cardiovascular side-effects such as sudden cardiac death, heart attack, stroke, hypertension, chest pain and abnormal heartbeat. Additionally, use of sildenafil may be associated with other side-effects including temporary vision loss, seizure, prolonged erection, headache, flushing, nasal congestion and abdominal pain. Sildenafil should not be used by individuals taking any type of nitrate drug (e.g., nitroglycerine) due to the risk of developing potentially life-threatening low blood pressure.